Jeffrey Conn

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders. Read More

Heidi Hamm, Ph.D. In their introductions of Heidi Hamm, Ph.D., prior to her Flexner Discovery Lecture last week, Susan Wente, Ph.D., and P. Jeffrey Conn, Ph.D., recounted how early encounters with her influenced their careers. For Wente, associate vice chancellor for… Read More

Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease. Read More

AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia. Read More

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read More

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners. Read More

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease. Read More

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects. Read More

Yasmine S. Ali, assistant clinical professor of medicine, has been elected chair of the Tennessee Medical Association’s Young Physician Section and will serve as its representative to the TMA board. Conn (Vanderbilt) Jeffrey Conn, director of Vanderbilt’s Center for Neuroscience Drug Discovery, has won the first Tennessee Governor’s Award… Read More

Reid Thompson talks with Lola Chambless in the neurosurgery OR. (Anne Rayner/VUMC) The May program for My Health Chat will be the fascinating field of neuroscience. Panelists will be Reid Thompson, chair of neurosurgery and director of the Vanderbilt Brain Tumor Center, and Jeff Conn,… Read More

Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience. Read More

With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County. Read More

The Center for Technology Transfer and Commercialization is taking Vanderbilt researchers’ inventions to new heights An array of instruments and gadgets found in the Olin Hall laboratory of Professor of Mechanical Engineering Michael Goldfarb. (John Russell/Vanderbilt) Use the term “inventor,” and what pops to mind? The wild-haired Dr. Emmett… Read More

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read More

The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read More

Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism. Read More

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain. Read More